How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/not-for-treatment-of-diabetic-ketoacidosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Not for treatment of diabetic ketoacidosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Not for treatment of diabetic ketoacidosis (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Not for treatment of diabetic ketoacidosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Prandin	repaglinide	Novo Nordisk	Glinide [EPC]	ATP-binding cassette sub-family C member 8		1997-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Novo Nordisk · 1 drug in Not for treatment of diabetic ketoacidosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Not for treatment of diabetic ketoacidosis:

Cite this brief

Drug Landscape (2026). Not for treatment of diabetic ketoacidosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/not-for-treatment-of-diabetic-ketoacidosis. Accessed 2026-06-10.

Not for treatment of diabetic ketoacidosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing